Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Objective : To evaluate the prognostic significance of microalbuminuria and overt diabetic nephropathy and other putative risk factors for cardiovascular and all cause mortality in insulin dependent diabetes. Design : Ten year observational follow up study. Setting : Outpatient diabetic clinic in a tertiary referral centre. Subjects : All 939 adults with insulin dependent diabetes (duration of diabetes five years or more) attending the clinic in 1984; 593 had normal urinary albumin excretion (</=30 mg/24 h), 181 persistent microalbuminuria (31-299 mg/24 h), and 165 overt nephropathy (>/=300 mg/24 h). Main outcome measure : All cause and cardiovascular mortality. Results : Fifteen per cent of patients (90/593) with normoalbuminuria, 25% (45/181) with microalbuminuria, and 44% (72/165) with overt nephropathy at baseline died during follow up. Cox multiple regression analysis identified the following significant predictors of all cause mortality: male sex (relative risk 2.03; 95% confidence interval 1.37 to 3.02), age (1.07; 1.06 to 1.08), height (0.96; 0.94 to 0.98), smoking (1.51; 1.09 to 2.08), social class V versus social class IV (1.70; 1.25 to 2.31), log 10 urinary albumin excretion (1.45; 1.18 to 1.77), hypertension (1.63; 1.18 to 2.25), log 10 serum creatinine concentration (8.96; 3.34 to 24.08), and haemoglobin A 1c concentration (1.11; 1.03 to 1.20). Age, smoking, microalbuminuria, overt nephropathy, and hypertension were significant predictors of cardiovascular mortality. Mortality in patients with microalbuminuria was only slightly increased compared with that in patients with normoalbuminuria. Median survival time after the onset of overt diabetic nephropathy was 13.9 years (95% confidence interval 11.8 to 17.2 years). Conclusions : Abnormally increased urinary albumin excretion and other potentially modifiable risk factors such as hypertension, smoking, poor glycaemic control, and social class predict increased mortality in insulin dependent diabetes. Microalbuminuria by itself confers only a small increase in mortality. The prognosis of patients with overt diabetic nephropathy has improved, probably owing to effective antihypertensive treatment. Key messages: Microalbuminuria predicts increased mortality due to progression to overt nephropathy Microalbuminuria by itself confers only a small increase in mortality after age 50 The prognosis in patients with insulin dependent diabetes complicated by nephropathy has improved, probably owing to treatment with antihypertensive agents
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
Mogensen, C. E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100605 · Cited by 1,908
MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS
Viberti, G. C., Jarrett, R. J., Mahmud, U., Hill, R. D., Argyropoulos, A., & Keen, H. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92450-3 · Cited by 1,663
Predicting Diabetic Nephropathy in Insulin-Dependent Patients
Mogensen, C. E., & Christensen, C. K. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407123110204 · Cited by 1,569
Reichard, P., Nilsson, B.-Y., & Rosenqvist, U. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307293290502 · Cited by 1,202
Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study
Andersen, A. R., Christiansen, J. S., Andersen, J. K., Kreiner, S., & Deckert, T. (1983) · Diabetologia · doi:10.1007/bf00284458 · Cited by 1,067
Inequalities in Death--Specific Explanations of a General Pattern?
Marmot, M. G., Shipley, M. J., & Rose, G. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92337-7 · Cited by 950
The changing natural history of nephropathy in type I Diabetes
Krolewski, A. S., Warram, J. H., Christlieb, A. R., Busick, E. J., & Kahn, C. R. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90284-0 · Cited by 777
Krolewski, A. S., Kosinski, E. J., Warram, J. H., Stevens Leland, O., Busick, E. J., Cader Asmal, A., Rand, L. I., Christlieb, A. R., Bradley, R. F., & Kahn, C. R. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91086-1 · Cited by 654
Cited by
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Hillege, H. L., Fidler, V., Diercks, G. F. H., van Gilst, W. H., de Zeeuw, D., van Veldhuisen, D. J., Gans, R. O. B., Janssen, W. M. T., Grobbee, D. E., & de Jong, P. E. (2002) · Circulation · doi:10.1161/01.cir.0000031732.78052.81 · Cited by 1,551
Kidney disease and increased mortality risk in type 2 diabetes
Afkarian, M., Sachs, M. C., Kestenbaum, B., Hirsch, I. B., Tuttle, K. R., Himmelfarb, J., & de Boer, I. H. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012070718 · Cited by 1,298
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000102971.85504.7c · Cited by 1,144
Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?
Martín-Timón, I. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.444 · Cited by 976
de Zeeuw, D., Remuzzi, G., Parving, H.-H., Keane, W. F., Zhang, Z., Shahinfar, S., Snapinn, S., Cooper, M. E., Mitch, W. E., & Brenner, B. M. (2004) · Circulation · doi:10.1161/01.cir.0000139860.33974.28 · Cited by 750
Self-citationKlausen, K., Borch-Johnsen, K., Feldt-Rasmussen, B., Jensen, G., Clausen, P., Scharling, H., Appleyard, M., & Jensen, J. S. (2004) · Circulation · doi:10.1161/01.cir.0000133312.96477.48 · Cited by 693
Self-citationMatough, F. A., Budin, S. B., Hamid, Z. A., Alwahaibi, N., & Mohamed, J. (2012) · Sultan Qaboos University Medical Journal · doi:10.12816/0003082 · Cited by 674
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638
“2)* Macroalbuminuria 578 40 (45)* 3 (3)* 18 (20)* 28 (31)* 89 (15.”
Chronic kidney disease as cause of cardiovascular morbidity and mortality
Vanholder, R., Massy, Z., Argiles, A., Spasovski, G., Verbeke, F., & Lameire, N. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh813 · Cited by 613
Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey
Jones, C. A., Francis, M. E., Eberhardt, M. S., Chavers, B., Coresh, J., Engelgau, M., Kusek, J. W., Byrd-Holt, D., Narayan, K. M. V., Herman, W. H., et al. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.31388 · Cited by 444
Endothelial Glycocalyx Damage Coincides With Microalbuminuria in Type 1 Diabetes
Nieuwdorp, M., Mooij, H. L., Kroon, J., Atasever, B., Spaan, J. A. E., Ince, C., Holleman, F., Diamant, M., Heine, R. J., Hoekstra, J. B. L., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1619 · Cited by 442
Urinary Albumin Excretion: An Independent Predictor of Ischemic Heart Disease
Borch-Johnsen, K., Feldt-Rasmussen, B., Strandgaard, S., Schroll, M., & Jensen, J. S. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.8.1992 · Cited by 437
Self-citationArterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease
Jensen, J. S., Feldt-Rasmussen, B., Strandgaard, S., Schroll, M., & Borch-Johnsen, K. (2000) · Hypertension · doi:10.1161/01.hyp.35.4.898 · Cited by 425
Self-citationWhat is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?
Satchell, S. C., & Tooke, J. E. (2008) · Diabetologia · doi:10.1007/s00125-008-0961-8 · Cited by 361
Use of the Albumin/Creatinine Ratio to Detect Microalbuminuria: Implications of Sex and Race
Mattix, H. J., Hsu, C.-Y., Shaykevich, S., & Curhan, G. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1341034 · Cited by 355
Orchard, T. J., Secrest, A. M., Miller, R. G., & Costacou, T. (2010) · Diabetologia · doi:10.1007/s00125-010-1860-3 · Cited by 313
Microvascular Dysfunction and Hyperglycemia: A Vicious Cycle With Widespread Consequences
Stehouwer, C. D. A. (2018) · Diabetes · doi:10.2337/dbi17-0044 · Cited by 306
Mining Electronic Health Records (EHRs): A Survey
Yadav, P., Steinbach, M., Kumar, V., & Simon, G. (2018) · ACM Computing Surveys · doi:10.1145/3127881 · Cited by 299
Gillies, C. L., Lambert, P. C., Abrams, K. R., Sutton, A. J., Cooper, N. J., Hsu, R. T., Davies, M. J., & Khunti, K. (2008) · BMJ · doi:10.1136/bmj.39545.585289.25 · Cited by 290
Diabetic Nephropathy in 27,805 Children, Adolescents, and Adults With Type 1 Diabetes
Raile, K., Galler, A., Hofer, S., Herbst, A., Dunstheimer, D., Busch, P., & Holl, R. W. (2007) · Diabetes Care · doi:10.2337/dc07-0282 · Cited by 278
Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas
Mogensen, C. E. (1999) · Diabetologia · doi:10.1007/s001250051151 · Cited by 274
Pambianco, G., Costacou, T., & Orchard, T. J. (2007) · Diabetes Care · doi:10.2337/dc06-2053 · Cited by 198
“Endothelial dysfunction, which has been shown to precede microalbuminuria by 2–3 years (42,43), has been suggested as the possible link to the concomitant development of the renal and cardiovascular complications often seen in type 1 diabetic patients (44,45).”
BackgroundGansevoort, R. T., Verhave, J. C., Hillege, H. L., Burgerhof, J. G. M., Bakker, S. J. L., De Zeeuw, D., & De Jong, P. E. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09408.x · Cited by 163
Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland
Asao, K., Sarti, C., Forsen, T., Hyttinen, V., Nishimura, R., Matsushima, M., Reunanen, A., Tuomilehto, J., Tajima, N., & for the Diabetes Epidemiology Research International (DERI) Mortality Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2037 · Cited by 102
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance
Apostolopoulou, M., Lambadiari, V., Roden, M., & Dimitriadis, G. D. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnae032 · Cited by 90
Bjerg, L., Hulman, A., Carstensen, B., Charles, M., Witte, D. R., & Jørgensen, M. E. (2019) · Diabetologia · doi:10.1007/s00125-019-4812-6 · Cited by 39
Rosenlund, S., Hansen, T. W., Rossing, P., & Andersen, S. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2839 · Cited by 19
“Patients with micro- or macroalbuminuria have an increased risk of cardiovascular and all-cause mortality compared with normoalbuminuria (17, 18).”
BackgroundSelf-citationCardoso, C. R. L., & Salles, G. F. (2008) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2008000800006 · Cited by 8
Metadata
- Authors
- Rossing, P., Hougaard, P., Borch-Johnsen, K., & Parving, H.-H.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1996-09-28
- Volume
- 313
- Issue
- 7060
- Pages
- 779-784
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2013093313
- Cited by
- 428
- References
- 31
- FWCI
- 8.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.